EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Review Article: Impact of Alcohol Consumption on the Development and Progression of Metabolic Dysfunction–Associated Steatotic Liver Disease

Yunxuan Lei, Yixuan Zhu, Wenjing Ni iD, Junping Shi iD, Wai-Kay Seto iD, Jie Li iD

Alimentary Pharmacology & Therapeutics · 2025

DOI: 10.1111/apt.70335 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Alimentary Pharmacology & Therapeutics, 2025. Verfasst von Yunxuan Lei und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Disease, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China. Hauptthemen laut MEDLINE: Alcohol Drinking, Fatty Liver. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 104 Literaturangaben. Gefördert von: Project supported by Medical Science and technology development Foundation, Nanjing Department of Health, Project of Institute of Chinese Medicine, Nanjing University/Aid Project of Nanjing Drum Tower Hospital Health, Education & Research Foundation, Nanjing science and technology bureau 2024 International/Hong Kong/Macau/Taiwan Science and Technology Cooperation Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Metabolic dysfunction–associated steatotic liver disease (MASLD) is recognised as a globally prevalent chronic liver disease, primarily driven by metabolic risk factors such as insulin resistance, obesity, dyslipidaemia and impaired glucose metabolism. Traditionally considered distinct from alcohol‐related liver disease, MASLD is increasingly being re‐evaluated in light of new evidence regarding the role of alcohol consumption.

Aims

To clarify the multifaceted effects of alcohol intake on the progression of MASLD. We focus on the underlying pathophysiological mechanisms, clinical implications and the challenges associated with risk stratification in affected individuals.

Methods

We conducted a narrative review of epidemiological and mechanistic studies on the interaction between alcohol intake and metabolic dysfunction in MASLD up to 30 June 2025.

Results

Accumulating evidence indicates that even moderate alcohol consumption can amplify hepatic steatosis through multiple interconnected mechanisms, including oxidative stress, disrupted lipid metabolism and gut microbiota dysbiosis. These changes trigger inflammatory cascades and accelerate the progression from simple steatosis to steatohepatitis, fibrosis and cirrhosis in individuals with underlying metabolic dysfunction. Epidemiological studies have revealed a dose‐dependent relationship between alcohol intake and liver disease severity, with synergistic effects particularly evident in patients with obesity or metabolic syndrome.

Conclusions

Alcohol amplifies MASLD progression through synergistic mechanisms. Standardised evaluation of alcohol use is critical for risk stratification and the development of personalised treatment strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alcohol DrinkingFatty LiverHumansDisease ProgressionRisk FactorsMetabolic SyndromeGastrointestinal MicrobiomeObesityInsulin ResistanceLipid MetabolismOxidative Stress

Stichwörter der Autor:innen

alcohol consumptionmetabolic dysfunction–associated fatty liver diseasesteatotic liver disease

Autor:innen und Institutionen

  • Department of Infectious Disease, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China.
  • Department of Infectious Diseases, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
  • Department of Translational Medicine Center, Affiliated Hospital of Hangzhou Normal University, Institute of Hepatology and Metabolic Diseases, Hangzhou Normal University, Hangzhou, China.
  • Department of Medicine and State Key Laboratory of Liver Research, the University of Hong Kong, Hong Kong, China.

ORCID-Profile: Wenjing Ni, Junping Shi, Wai-Kay Seto, Jie Li

Förderung

  • Project supported by Medical Science and technology development Foundation, Nanjing Department of Health
  • Project of Institute of Chinese Medicine, Nanjing University/Aid Project of Nanjing Drum Tower Hospital Health, Education & Research Foundation
  • Nanjing science and technology bureau 2024 International/Hong Kong/Macau/Taiwan Science and Technology Cooperation Project
  • Nanjing Drum Tower Hospital Clinical Research Special Fund project (No. 2024-LCYJ-PY-53)

Zitieren

APA

Lei, Y., Zhu, Y., Ni, W., Shi, J., Seto, W. K., & Li, J. (2025). Review Article: Impact of Alcohol Consumption on the Development and Progression of Metabolic Dysfunction–Associated Steatotic Liver Disease. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.70335

Vancouver

Lei Y, Zhu Y, Ni W, Shi J, Seto WK, Li J. Review Article: Impact of Alcohol Consumption on the Development and Progression of Metabolic Dysfunction–Associated Steatotic Liver Disease. Alimentary Pharmacology & Therapeutics. 2025. doi:10.1111/apt.70335

BibTeX
@article{Lei2025,
  author = {Lei, Yunxuan and Zhu, Yixuan and Ni, Wenjing and Shi, Junping and Seto, Wai-Kay and Li, Jie},
  title = {Review Article: Impact of Alcohol Consumption on the Development and Progression of Metabolic Dysfunction–Associated Steatotic Liver Disease},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2025},
  doi = {10.1111/apt.70335}
}
Kostenlos starten →